Back to search
FDAFDA · Food and drugs·Recall number D-0942-2017

Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, Manufactured by: Lantheus MI Radiopharmaceuticals, Inc., San Juan, PR --- NDC 11994-015-01

Published July 12, 2017 · Recall initiated: May 18, 2017

Summary

FDA records drug Class III recall D-0942-2017, published July 12, 2017 and initiated May 18, 2017. Recalling firm: Lantheus MI Radipharmaceuticals Inc.; Status: Terminated; Reported quantity: 26 doses; Lot: Lot: FDG170518-01, exp 5/18/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Lantheus MI Radipharmaceuticals Inc.
Distributor
Puerto Rico
Lot
Lot: FDG170518-01, exp 5/18/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, Manufactured by: Lantheus MI Radiopharmaceuticals, Inc., San Juan, PR --- NDC 11994-015-01 recalled?

Yes. FDA published recall D-0942-2017 on July 12, 2017. Reported hazard: Failed Impurities/Degradation Specifications; out of specification result for Acetonitrile residual solvent

What should I do if I have this product?

Voluntary: Firm initiated · Telephone